Industrials

Key growth drivers in the biodegradable plastic market include favorable governmental policies, increasing demand for eco-friendly packaging, and heightened environmental awareness. The industry is particularly driven by applications in packaging, agriculture, and consumer goods, with significant growth potential in the U.S., UK, India, and UAE. Challenges such as limited raw materials and performance issues persist, yet technological advancements and corporate sustainability initiatives present promising opportunities. Major players like Total Corbion and Mitsubishi Chemical are expanding their footprint with innovative solutions in the market.

LARBERT, United Kingdom, June 11, 2025 (GLOBE NEWSWIRE) -- (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (NFI) a leader in propulsion-agnostic bus and coach mobility solutions, announced today that its subsidiary, Alexander Dennis Limited (Alexander Dennis), is entering into a consultation on a new strategy for its United Kingdom (UK) manufacturing operations. The refocused strategy results from the completion of a detailed business review and is intended to adjust the UK business to changing market dynamics.

The avionics market is set to expand from USD 56.22 billion in 2025 to USD 82.33 billion by 2030 at a CAGR of 16.8%, driven by increasing demand for advanced aircraft systems. Commercial aviation will lead the market, aided by advancements in navigation systems and evolving air traffic management, such as SESAR and NextGen. North America is expected to dominate, benefiting from significant defense investments and a focus on avionics retrofits. Key players like RTX, Honeywell, L3Harris, GE, and Thales are advancing technologies, enhancing safety and efficiency. For market insights, the report covers competitive analysis, growth strategies, and recent innovations.

mRNA Market Surges: The global mRNA market is booming, fueled by the success of COVID-19 vaccines, with applications expanding to cancer and genetic disorders. Driven by public-private investments, the industry sees pharmaceutical giants like Pfizer and Moderna spearheading innovations. Despite challenges such as high costs, the market is set for substantial growth through 2035, with North America leading due to its robust healthcare infrastructure. Recent collaborations, such as Etherna Immunotherapies with Dropshot Therapeutics, are further accelerating RNA therapeutic developments.